Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy
Clinical trial NCT02501551 · UNKNOWN
Trial details
- NCT number
- NCT02501551
- Sponsor
- Yonsei University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2022-05-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.